The Report Guru

The global laboratory information systems market size is projected to reach USD 4.0 billion by 2028, from USD 2.4 billion in 2023, at a CAGR of 10.8% from 2023 to 2028. The growth of this market is influenced primarily due to the increasing adoption of LIS in biobanks and biorepositories, as well as the development of integrated LIS and the need to curtail escalating healthcare costs. However, high maintenance and service costs are expected to restrain the market growth during the forecast period. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232312738 The laboratory information systems (LIS) industry is witnessing several key trends that are shaping its development and future trajectory. There is a growing emphasis on interoperability and integration of LIS with other healthcare systems. Many LIS systems now offer mobile applications, allowing laboratory staff to access patient data, test results, and other information on their smartphon

The preclinical imaging market is poised for significant growth in the coming years. According to the report “Preclinical Imaging Market size by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) – Global Forecast to 2029,” the market is expected to reach USD 1,259 million by 2029 from USD 946 million in 2024, at a CAGR of 5.9%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 Market Dynamics and Growth Drivers The preclinical imaging market is driven by several factors. Increasing funding for preclinical research is a primary catalyst, alongside the development of cost-effective imaging systems. The rising demand for new drug development and noninvasive small-animal imaging techniques also significantly boosts the market. These factors collectively drive advancements and the adoption of preclinical

Human Identification Market  in terms of revenue was estimated to be worth $0.8 billion in 2024 and is poised to reach $1.3 billion by 2029, growing at a CAGR of 10.7% from 2024 to 2029 according to a new report by MarketsandMarkets™. In recent years, there has been substantial growth in the human identification market, driven primarily by the increasing public-private investments in the forensic science industry, and rising awareness of DNA testing technology and its application among forensic experts. Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology, among other applications, with DNA analysis/profiling being a key tool in this sector. However, high cost of forensic tools and services may restrain the growth of human identification market during forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100607777 Browse in-depth TOC on "Human Identification Market&

The global Breast Imaging Market  in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $6.6 billion by 2028, growing at a CAGR of 8.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The major factors driving the growth of this market include rising awareness campaigns, increasing public-private investments, and lucrative opportunities in emerging markets. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897 Browse in-depth TOC on “Breast Imaging Market” 244 – Tables 37 – Figures 266 – Pages Non-ionizing breast imaging technologies segment to register significant growth rate over the forecast period of 2023-2028 Based on the technology, the global breast imaging market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. The non-ionizing breast imaging technologies segment is anticipated to register the highest growth rate over the forecast pe

The Microbiome Sequencing Services Market  in terms of revenue was estimated to be worth $284 million in 2022 and is poised to reach $555 million by 2028, growing at a CAGR of 14.3% from 2022 to 2028 according to a new report by MarketsandMarkets™. Key driving factors of the microbiome sequencing services market growth include, expanding applications for metagenomic sequencing, high focus on development of human microbiome therapeutics, and high costs associated with sophisticated sequencing instruments. In recent years, there has been a significant increase in the demand for metagenomic sequencing in the field of microbiome research owing it its wide array of applications, such as disease diagnosis, drug discovery, and precision medicine. This is expected to boost the market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380 Browse in-depth TOC on "Microbiome Sequencing Services Market" 186 - Tables 35 - Figures 200 -

The global gene editing market size in terms of revenue, was estimated at .3 billion in 2023 and is projected to reach .6 billion by 2028, showcasing a remarkable compound annual growth rate (CAGR) of 15.0% from 2023 to 2028. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 OPPORTUNITY: Expanding pipeline for gene therapy The expanding pipeline for gene therapy in the gene editing industry presents significant opportunities for advancements in treating genetic disorders and other diseases. Gene therapy involves the delivery of therapeutic genes or gene editing tools into the patient’s cells to correct genetic mutations, restore normal gene function, or introduce therapeutic genes for targeted treatment. The growing number of gene therapy candidates in the development pipeline highlights the potential for transformative breakthroughs in personalized medicine and the treatment of previously incurable diseases. CHALLENGE: High equipmen